Measuring patient experiences in Europe: what can we learn from the experiences in the USA and England?
Notice bibliographique
Résumé
There is a growing interest in measuring patients’ experiences in health care. In several European countries, surveys are taking place to map the quality of care as perceived by patients. In a number of countries, this is part of a systematic programme of work that is undertaken at regular intervals. According to a review commissioned by the Organization for Economic Cooperation and Development (OECD), this is the case in Denmark, Norway, England and The Netherlands. Outside Europe, systematic evaluation of patients’ experiences takes place in Canada and the USA. In addition to these national programmes, the Commonwealth Fund, the Picker Institute Europe and the World Health Organization (WHO) have undertaken cross-national comparisons of patients’ experiences.1 The USA and England have by far the longest tradition of measuring patients’ experiences through, respectively, the American CAHPS (Consumer Assessment of Healthcare Providers and Systems) surveys and the surveys of the Picker Institute Europe for the English NHS. These programmes can serve as examples for European health care systems when it comes to measuring patients’ experiences. Countries that wish to embark on systematic and regular evaluations of quality of care from the perspective of patients can learn from the American and English experiences in this field. What are the main lessons learned in these countries? In the 1990s, patient satisfaction had become a widely accepted outcome measure in trials testing new drugs or interventions. In addition to that, patient satisfaction surveys were used to measure the quality of care from the perspective of the health care user. In the second half of the 1990s, however, it became clear that as a tool for quality improvement, patient satisfaction surveys were neither very sensitive nor very useful. One of the problems with patient or consumer satisfaction is its ambiguity. Satisfaction is a multidimensional concept, based on a relationship between experiences and expectations. It was argued that for continuous quality improvement it would be more fruitful to look at the underlying components of the concept: expectations and experiences.2 This led to the development of new ‘families’ of patient surveys, in which the emphasis is not on an evaluation of satisfaction but on collecting detailed reports of what actually happened to patients during a hospital stay or a visit to the doctor. The questionnaires used by the Commonwealth Fund, CAHPS and the Picker Institute Europe are the examples of those new types of surveys, that in turn have inspired the development of similar patient surveys in other countries, e.g. the Consumer Quality Index in The Netherlands.3 The reasons for studying patient experiences can differ between countries. The motives vary from external accountability of health care providers to enhancing patient choice, improving the quality of care or measuring the performance of the health care system as a whole. Often, patient experience surveys serve multiple purposes. For example, the work of the Picker Institute in the English NHS aims at providing comparative information for the Care Quality Commission (previously the Healthcare Commission) and the public. Therefore, they serve external accountability and consumer choice. However, at the same time, providers use the results for internal quality improvement. To that end, the Picker Institute offers ‘Guides to Improvement’. If the goal is consumer choice, this requires a comparison of patient experiences across health care facilities. Comparison in turn asks for the standardization of questionnaires and methods. The development of the American CAHPS surveys was an explicit attempt to standardize patient surveys in order to make consumer report cards. In other words, the initial aim of CAHPS was to facilitate consumer choice. However, recently the CAHPS consortium too has put considerable effort into the development of the so-called ‘CAHPS Improvement Guide’; a guide for health plans and health care providers seeking to improve their performance in the domains of quality measured by CAHPS surveys. How do surveys like these help to improve the quality of care? According to Berwick, measuring quality indicators can improve the quality of care along two routes: selection or change.4 Selection takes place if public reporting of quality indicators stimulates individual consumers or their agents to choose better performing providers over worse ones. Change takes place if (internal) feedback on performance stimulates providers to engage in quality improvement activities. Fung et al.5 have reviewed the American experiences with public reporting of performance indicators. She found that evidence for a relation between public reporting of performance indicators and the quality of patient care is scant. However, the little available evidence suggests that: No, individual consumers do not often use this information (yet) to select better performing providers over worse performing ones; but, Yes, publicly releasing performance data stimulates quality improvement activity at the hospital level. If this holds true for comparative information about patient experiences, the publication of these data can trigger health care providers to initiate quality improvement projects, even if individual consumers do not use this information in the choice of providers. Given this link between publication and improvement, the instruments used for external accountability and consumer choice should also be useful for internal quality projects. Therefore, an integrated data system for quality measurement and reporting is required, as James6 already argued in 2003. From the work conducted in the USA and England, European countries who wish to introduce similar programmes of measuring quality of care from the patient's perspective can learn at least three things: measure detailed patient experiences instead of overall patient satisfaction; introduce an integrated system for: internal quality measurement and improvement on the one hand, and external reporting and accountability on the other hand; and standardize questionnaires and methods. However, this is probably easier said than done. This goes particularly for the last two recommendations: the use of integrated systems and standardization. The introduction of an integrated system for internal measurement and improvement and external accountability implies that all stakeholders involved have to agree on what is being measured, and how and when. This means that the researchers who develop patient experience questionnaires must work miracles. Their questionnaires should meet the information needs of individual patients, doctors and managers, health insurers and watchdogs such as the Care Quality Commission in England or the Inspectorate for Health Care in The Netherlands. Stakeholder involvement is a prerequisite for collecting information once and then using it for multiple purposes. Through stakeholder involvement, researchers must try to incorporate the needs of all the potential users of the information. In this process, they should pay specific attention to the involvement of patients and patient organizations. Because if public reporting of patient experiences can trigger doctors and managers to improve care delivery, it is essential that reporting takes place about those quality domains that matter most to patients. If reporting takes place only about topics such as parking lots or interior design, than those are the kinds of things that health care managers will worry about. If we want them to worry about core domains of quality of care, then that is what we need to measure and report. Stakeholder involvement is necessary at several stages in the process of evaluating patient experiences, not just in the phase of questionnaire construction. If public reporting can trigger quality improvement, it means that we have to make sure that the information is useful for health care managers and professionals who are responsible for the quality of care. Therefore, they have to be involved in the design of information products based on patient surveys. Moreover, following the example of CAHPS and Picker, guidance should be provided to professionals and managers in the form of ‘improvement guides’ and/or tailored advice. This guidance must be based on thorough research. We need to evaluate to what extent patient surveys offer actionable indicators that can be used in a plan-do-check-act cycle of quality improvement. For example, in a Dutch survey we found that 40% of the cataract patients report that they had not been informed about possibly alarming symptoms that they should pay attention after hospital discharge.7 What does that mean? What happens when patients are informed about what (not) to do after discharge? Who tells them? Are patients told in a context in which they do not or cannot pay attention, or are they not told at all? Do they get an information leaflet? Is that written in a language they can understand? How exactly do doctors and nurses have to change their behaviour or their routines in order to improve this outcome? Often, patient experiences are measured with the purpose of comparing the performance of different health care facilities. This is relevant both for consumer choice or selective contracting by insurers as well as for quality improvement through benchmarking. The wish to compare the performance of providers calls for standardization of questionnaires and methods. After all, we want to measure differences in performance, not differences in the wording of questions or in the composition of study samples. For practical reasons, standardization—if at all—takes place on the national level. And even at this level, it is difficult enough to get national stakeholders to agree on what should be measured and how. Nevertheless, there are at least two reasons why international standardization might be relevant. First, there is an interest in comparing the performance of health care systems. Ever since the WHO published its World Health Report 2000, the quality of care as perceived by patients (the so-called ‘responsiveness’) has been seen as an integral part of the performance of systems. Therefore, in November 2007 OECD Member Countries endorsed plans to develop internationally comparable measures of responsiveness or patient experiences under the auspice of the Health Care Quality Indicators Project. Secondly, there is the issue of consumer choice. In border regions in particular, citizens of the EU are becoming increasingly aware of the possibilities of cross-border health care consumption. Comparative information about the quality of care on both sides of the border should therefore be available. Last year, the European Commission proposed a directive of the European Parliament and of the Council on the application of patients’ rights in cross-border healthcare.8 In the draft text of this proposal, the Commission argues: ‘If patients cannot have access to the key medical, financial and practical information relevant to the healthcare that they are seeking, this clearly would constitute an obstacle to their freedom to receive health services in another Member State by making it difficult for patients to make a rational and informed choice between different providers including providers in other Member States’. Information about the experiences that previous patients had with certain providers is relevant for patient choice.9 In other words, patient experiences form part of the ‘key medical, financial and practical information’ that the Commission mentions. Therefore, the question of standardization of patient surveys needs to be addressed in a European context.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction machine sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.
Scores du classifieur distillé par catégorie (deux têtes)
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,020 | 0,046 |
| Méta-épidémiologie (sens strict) | 0,001 | 0,000 |
| Méta-épidémiologie (sens large) | 0,002 | 0,001 |
| Bibliométrie | 0,003 | 0,006 |
| Études des sciences et des technologies | 0,003 | 0,004 |
| Communication savante | 0,009 | 0,020 |
| Science ouverte | 0,001 | 0,006 |
| Intégrité de la recherche | 0,003 | 0,005 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,004 | 0,001 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».